top of page
aes sol ball.png
Curved White Lines

Our Partners In Aesthetics Solutions Divison

Sinclair-Symbol-and-Typemark-GRAD-RGB-PT.png

Orginally known as Sinclair Pharma, the organisation has grown and flourished under the ownership of Huadong Medicine over the past four years. Our product range and breadth has expanded to include new and innovative brands and has done so by drawing upon a pool of outstanding talent both internally and externally within the aesthetic dermatology industry.

logo_sunekos_injectable.png

Sunekos Laboratories are the Aesthetic Division of Professional Dietetics, an Italian R&D Company specialized in Amino Acid-based formulas for medical use. Sunekos Laboratories, thanks to an incessant exchange with the scientific community, is where Sunekos Injectable & Sunekos Professional Line are born and designed. Our R&D is to exploit Amino Acids' biological diversity and synergy with Hyaluronic Acid to restore skin health and its physiological balance.

viber_image_2026-03-08_13-38-25-370_edited.png

CGBio  is a global biomedical company known for its advanced biomaterial technologies. Facetem, its latest CaHA dermal filler, represents one of the most modern calcium hydroxylapatite solutions globally, designed for structural support, biostimulation, and long-lasting aesthetic outcomes.

viber_image_2026-05-03_14-42-28-076.png

REVITACARE is a French Laboratory, founded in 2003, specialized in research, design, manufacturing of medical devices based on hyaluronic acid, dedicated to aesthetic medicine and cosmetology to prevent, correct the skin aging and treat hair problems.

Nabota.png

Daewoong Pharmaceutical is one of South Korea’s most prominent pharmaceutical groups. Nabota is its globally recognized botulinum toxin, distinguished by high purity, consistent clinical performance, and approvals across multiple international markets.

pharmaresearch_corporation_logo.jpg

PharmaResearch is a leading South Korean biopharmaceutical company specializing in regenerative medicine, built around its proprietary DOT™️ technologies for PDRN and PN. Through extensive research, manufacturing expertise, and continuous innovation in tissue regeneration, PharmaResearch has developed a global portfolio spanning pharmaceuticals, medical devices, and aesthetics. At the heart of its aesthetic portfolio is REJURAN®️, the original DOT™️ PN injectable platform and one of Korea’s most recognized innovations in regenerative aesthetics, with an expanding international presence across Asia, Europe, and other global markets.  

bottom of page